Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.
Saroj Vadhan‐Raj(The University of Texas MD Anderson Cancer Center), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Francisco X. Real(Universitat Pompeu Fabra), Mathilde Krim, Clare Gnecco, Susanna Cunningham–Rundles(NewYork–Presbyterian Hospital), George Y. Wong(Maimonides Medical Center), Herbert F. Oettgen
PubMed
January 1, 1986
Cited by 107
Related Papers
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
|Journal of Clinical Oncology|2011|1.3k
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
|The Lancet|2005|631
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
|The Journal of Experimental Medicine|1982|577